Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PROPYLTHIOURACIL Cause Therapy non-responder? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Therapy non-responder have been filed in association with PROPYLTHIOURACIL (Propylthiouracil). This represents 0.7% of all adverse event reports for PROPYLTHIOURACIL.

7
Reports of Therapy non-responder with PROPYLTHIOURACIL
0.7%
of all PROPYLTHIOURACIL reports
0
Deaths
1
Hospitalizations

How Dangerous Is Therapy non-responder From PROPYLTHIOURACIL?

Of the 7 reports, 1 (14.3%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PROPYLTHIOURACIL. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does PROPYLTHIOURACIL Cause?

Drug ineffective (121) Foetal exposure during pregnancy (110) Anti-neutrophil cytoplasmic antibody positive vasculitis (81) Exposure during pregnancy (75) Hyperthyroidism (58) Off label use (54) Maternal exposure during pregnancy (50) Agranulocytosis (42) Vasculitis (41) Premature baby (38)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Which PROPYLTHIOURACIL Alternatives Have Lower Therapy non-responder Risk?

PROPYLTHIOURACIL vs PROTAMINE PROPYLTHIOURACIL vs PROTHIPENDYL PROPYLTHIOURACIL vs PROTIONAMIDE PROPYLTHIOURACIL vs PROTONIX PROPYLTHIOURACIL vs PROTOPIC

Related Pages

PROPYLTHIOURACIL Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder PROPYLTHIOURACIL Demographics